Cover Image
市場調查報告書

腎上腺功能障礙的全球市場分析

Adrenal Insufficiency Market Report: 2016 Edition

出版商 Koncept Analytics 商品編碼 361716
出版日期 內容資訊 英文 45 Pages
訂單完成後即時交付
價格
Back to Top
腎上腺功能障礙的全球市場分析 Adrenal Insufficiency Market Report: 2016 Edition
出版日期: 2016年06月30日 內容資訊: 英文 45 Pages
簡介

本報告提供全球副腎功能衰竭市場相關分析,關於疾病概要和主要的治療方法,全球及各地區、主要國家的市場趨勢 (患病人數,市場規模 (以金額為準)),主要的推動及阻礙市場要素,企業間競爭趨勢,主要企業簡介等的調查評估。

第1章 市場概要

  • 簡介
    • 皮質醇低價值
    • 醛固酮低值
    • 去氫表雄固酮低值
  • 症狀
    • 腎上腺功能障礙
    • 腎上腺發病
  • 病因
    • 原發性腎上腺功能障礙
    • 次發性腎上腺功能障礙
  • 預防
  • 診斷
    • 血中荷爾蒙檢驗、尿液檢查
    • 腎上腺發病的檢驗
  • 治療選擇

第2章 全球腎上腺功能障礙市場

  • 腎上腺功能障礙的患病人數
  • 腎上腺功能障礙的市場規模 (以金額為準)
  • 腎上腺功能障礙的患病人數:各類型
  • 各地區的市場趨勢
    • 各地區的患病人數
    • 各地區的市場規模 (以金額為準)

第3章 各地區市場

  • 美國市場
    • 兒童性腎上腺功能障礙的患病人數
    • 兒童性腎上腺功能障礙的市場規模 (以金額為準)
    • 成人性腎上腺功能障礙的患病人數
    • 成人性腎上腺功能障礙的市場規模 (以金額為準)
  • (EU5歐洲主要5個國家)

第4章 市場動態

  • 推動市場成長要素
    • 醫療費負擔的增加
    • 處方藥的銷售額增加
    • 自體免疫疾病的發病率的上升
    • 醫藥品的支出額的增加
    • 女性人口的增加
    • 孤兒藥市場成長
  • 市場趨勢
    • 糖皮質激素口服藥的替代
    • 腎上腺的移植
    • 替代療法
    • 病因的慢性海洛因成癮
  • 課題
    • 未診斷的疾病
    • 要往往被無視的症狀

第5章 競爭環境

  • 腎上腺功能障礙市場今後的銷售額、競爭形勢
  • 腎上腺功能障礙企業的市值比較

第6章 企業簡介

  • Bristol Myers Squibb
    • 產業概要
    • 主要的財務指標
    • 產業策略
  • Novartis
  • Pfizer Inc.
  • StrongBridge Biopharma

圖表一覽

目錄

Adrenal Insufficiency is a rare disease in which the adrenal glands are unable to produce sufficient amount of the hormones cortisone, aldosterone or Dehydroepiandrosterone, which are essential for vital functions of the human body. Cortisol in particular is very important for life and its deficiency can lead to the inability of the body to cope with intense stress. This condition can be life threatening, the sudden and severe worsening of which is called adrenal crisis. Common symptoms of adrenal insufficiency are fatigue, muscle weakness, loss of appetite, weight loss, and abdominal pain.

Adrenal insufficiency can be of two types, namely primary or secondary adrenal insufficiency. Primary adrenal insufficiency, also called Addison's disease occurs when the adrenal glands cannot produce sufficient amount of the adrenal hormone cortisol or aldosterone. Secondary adrenal insufficiency occurs when the pituitary gland is unable to produce enough amount of adrenocorticotropic hormone (ACTH), the lack of which drops cortisol production resulting in the shrinkage of adrenal glands. The most common cause of adrenal insufficiency is autoimmune diseases like rheumatoid arthritis, pernicious anemia and lupus erythematosus etc., while infections like tuberculosis are also known to cause the disease. It can be diagnosed through tests like Hormonal Blood and Urine Tests.

The entire adrenal insufficiency market can be subdivided into the market for pediatric and adult insufficiency, the latter of which constitutes a massive share. Further, cortisol deficiency records higher prevalence and market among other adrenal hormones. The Adrenal Insufficiency market is characterized by few competitors, specialist providers and known patient groups which are driven by factors like escalating healthcare spending, increasing sales of prescription drugs, rising spending on medicines and growing market for orphan drugs. In recent years, treatment market of this disease has been witnessing increased medical research for alternative therapies like transplantation of adrenal glands. However, symptoms of the disease are often ignored, leaving the market largely underdiagnosed.

The report "Adrenal Insufficiency Market" analyzes the development of this market, with focus on the United States and Europe. Major trends, growth drivers as well as issues being faced by the industry are discussed in detail in the report along with the present and upcoming competition in the market. q

Table of Contents

1. Market Overview

  • 1.1 Introduction
    • 1.1.1 Cortisol Insufficiency
    • 1.1.2 Aldosterone Insufficiency
    • 1.1.3 Dehydroepiandrosterone Insufficiency
  • 1.2 Symptoms
    • 1.2.1 Adrenal Insufficiency
    • 1.2.2 Adrenal Crisis
  • 1.3 Causes
    • 1.3.1 Primary Adrenal Insufficiency
    • 1.3.2 Secondary Adrenal Insufficiency
  • 1.4 Prevention
  • 1.5 Diagnosis
    • 1.5.1 Hormonal Blood and Urine Tests
    • 1.5.2 Test for Adrenal Crisis
  • 1.6 Treatment Options

2. Global Adrenal Insufficiency Market

  • 2.1 Global Adrenal Insufficiency Prevalence
  • 2.2 Global Adrenal Insufficiency Market by Value
  • 2.3 Global Adrenal Insufficiency Prevalence by Type
  • 2.4 Global Adrenal Insufficiency Market by Region
    • 2.4.1 Global Adrenal Insufficiency Prevalence by Region
    • 2.4.2 Global Adrenal Insufficiency Market Value by Region

3. Regional Markets

  • 3.1 The U.S. Cortisol Deficiency Market
    • 3.1.1 Pediatric Cortisol Deficiency Prevalence
    • 3.1.2 Pediatric Cortisol Deficiency Market by Value
    • 3.1.3 Adult Cortisol Deficiency Prevalence
    • 3.1.4 Adult Cortisol Deficiency Market by Value
  • 3.2 EU5 Cortisol Deficiency Market
    • 3.2.1 Pediatric Cortisol Deficiency Market by Prevalence
    • 3.2.2 Pediatric Cortisol Deficiency Market by Value
    • 3.2.3 Adult Cortisol Deficiency Market by Prevalence
    • 3.2.4 Adult Cortisol Deficiency Market by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Escalating Healthcare Spending
    • 4.1.2 Increasing Sales of Prescription Drugs
    • 4.1.3 Rising Incidence of Autoimmune Disease
    • 4.1.4 Rising Spending on Medicines
    • 4.1.5 Increasing Female Population
    • 4.1.6 Growing Market for Orphan Drugs
  • 4.2 Trends
    • 4.2.1 Oral Glucocorticoid Replacement
    • 4.2.2 Transplantation of Adrenal Glands
    • 4.2.3 Alternate Therapies
    • 4.2.4 Chronic Heroin Dependence as a Cause
  • 4.3 Challenges
    • 4.3.1 Underdiagnosed Disease
    • 4.3.2 Symptoms Often Ignored

5. Competitive Landscape

  • 5.1 Adrenal Insufficiency Upcoming Competition by Sales
  • 5.2 Adrenal Insufficiency Market Cap Comparison

6. Company Profiles

  • 6.1 Bristol Myers Squibb
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Novartis
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Pfizer Inc.
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 StrongBridge Biopharma
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Global Adrenal Insufficiency Prevalence (2015)
  • Global Adrenal Insufficiency Market by Value (2015)
  • Global Adrenal Insufficiency Prevalence by Type (2015)
  • Adrenal Insufficiency Prevalence by Region (2015)
  • Global Adrenal Insufficiency Market Value by Region (2015)
  • The U.S. Pediatric Cortisol Deficiency Prevalence (2015)
  • The U.S. Pediatric Cortisol Deficiency Market by Value (2015)
  • The U.S. Adult Cortisol Deficiency Prevalence (2015)
  • The U.S. Adult Cortisol Deficiency Market by Value (2015)
  • The EU5 Pediatric Cortisol Deficiency by Prevalence (2015)
  • The EU5 Pediatric Cortisol Deficiency by Value (2015)
  • The EU5 Adult Cortisol Deficiency by Prevalence (2015)
  • The EU5 Adult Cortisol Deficiency Market by Value (2015)
  • Global Healthcare Spending (2007-2015E)
  • Global Sales of Prescription Drugs (2010-2015E)
  • Rheumatoid Arthritis Prevalence in the U.S. (2015-2020E)
  • Global Spending on Medicines (2010-2020E)
  • Global Female Population (2009-2015)
  • Global Orphan Drugs Market (2010-2015E)
  • Bristol Myers Revenue Share by Region (2015)
  • Bristol Myers Revenue and Net Income (2011-2015)
  • Novartis Revenue by Business Segments (2015)
  • Novartis Revenue and Net Income (2012-2015)
  • Pfizer Revenue Share by Business Segments (2015)
  • Pfizer Revenue and Net Income (2011-2015)
  • StrongBridge BioPharma Revenue and Net Income (2018E-2025E)

List of Tables

  • Adrenal Insufficiency Upcoming Competition Sales Comparison (2015)
  • Adrenal Insufficiency Market Cap Comparison (2015)
  • StrongBridge Product Portfolio
Back to Top